Healthcare Interoperability Spend to Hit $21.5B by 2030 as 50% of CIOs Plan 5-20% Increases

Interoperability Budget Growth Outpaces Core Clinical IT

The global healthcare interoperability market will grow from $6.2 billion in 2021 to $21.5 billion by 2030 at a 14.9% compound annual growth rate, according to Allied Market Research. The trajectory means interoperability is shifting from a project line item to a sustained budget category that grows faster than many core clinical IT segments.

For CIOs, this creates justification for multi-year operating budget increases rather than one-off capital allocations. It also signals intensified vendor competition: EHR incumbents like Epic and Oracle Health are bundling FHIR APIs and data platforms against interoperability specialists including Health Gorilla, Redox, and Lyniate. In RFP negotiations, buyers can press major vendors on pricing by positioning independent integration platforms as credible alternatives in a $20 billion market.

The forecast assumes continued regulatory pressure and rising data liquidity demands from payers, patients, and public health agencies. Health systems that hold interoperability budgets flat will fall behind peers on exchange capability, increasing exposure under information-blocking rules and payer contract expectations.

Half of CIOs Plan 5-20% Spending Increases This Year

Health Gorilla's State of Interoperability report shows over 50% of health system CIOs plan to increase interoperability spending by 5-20% compared with the prior year. The report cites advances in FHIR-based APIs and TEFCA-aligned exchange networks as primary drivers.

This planned increase provides a peer-referenced benchmark for FY26 budget planning. If your organization's interoperability allocation is flat or shrinking, expect questions from board members and regulators. The spending bump favors network-as-a-service vendors like Health Gorilla, Particle Health, and Avaneer Health, as well as API-first platforms like Redox and Zus Health that position as faster alternatives to custom HL7 interfaces.

Buyers should respond by demanding volume-based discounts on transactions or connected endpoints and multi-year pricing caps for FHIR gateways and HIE services. Vendors know the money is coming; use that knowledge to lock in better terms before budget cycles close.

Federal Data Shows 70%+ Exchange Rates in Cleveland, Miami, Detroit

The U.S. Office of the National Coordinator for Health IT published city-level interoperability data showing that more than 70% of hospitals in Cleveland, Miami, and Detroit send, receive, find, and integrate electronic health information with external organizations. The data brief confirms meaningful regional variation, but in high-penetration metros, basic exchange is no longer a competitive differentiator.

Health systems in these markets should adjust RFP scoring criteria to emphasize advanced capabilities—care coordination workflows, real-time clinical decision support, social determinants integration—rather than basic CCD or ADT exchange. Vendors that demonstrate coverage across long-tail partners like post-acute facilities and community organizations will have an edge over point-to-point interface models.

For organizations operating below the 70% benchmark in their region, expect increased board scrutiny and pressure to accelerate integration platform investments or HIE participation. Failure to exchange data in high-interoperability metros increases legal and reputational risk under information-blocking enforcement and payer contract provisions.

FHIR-First Architectures Gain Traction in Mid-Size Organizations

Edenlab, a health IT engineering firm, published technical guidance on interoperability strategies for medium-sized healthcare organizations. The guide recommends FHIR-first architectures with a shared data layer decoupled from EHR silos, addressing fragmented legacy systems common in hospitals and clinics that lack the scale of integrated delivery networks.

The guidance reflects a broader shift: mid-market buyers are adopting modular integration strategies that separate data exchange from core EHR contracts. This creates opportunities to negotiate with neutral data platforms and reduces lock-in risk with a single EHR vendor. For medium-sized organizations, FHIR standards enable incremental migration from HL7 v2 interfaces without requiring a full EHR replacement.

CIOs should evaluate whether their current architecture allows for a shared FHIR layer. If your integration strategy ties every new data source to a specific EHR instance, you are building technical debt that will compound as exchange volume grows.

What to Watch

Track TEFCA Qualified Health Information Network (QHIN) designations and participation rates over the next six months. As more payers and health systems join TEFCA networks, organizations outside the framework will face higher costs to connect with trading partners. Budget conversations should include QHIN participation costs versus the alternative of maintaining bilateral connections.

Monitor EHR vendor responses to the planned 5-20% spending increases. Expect Epic, Oracle Health, and MEDITECH to bundle interoperability services more aggressively into core contracts to defend market share against independent platforms. Use this competitive pressure to renegotiate pricing or to carve out interoperability spend for best-of-breed vendors.

Finally, if you operate in a metro where ONC data shows exchange rates below 70%, prepare for regulatory or payer scrutiny. Compliance teams should audit current exchange capabilities and document gaps, and procurement teams should prioritize interoperability vendor evaluations before the next budget cycle.